ETEstefania Torres-Valdez

Estefania Torres-Valdez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Estefania Torres-Valdez has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reproductive health in Mexican women with systemic lupus erythematosus: pregnancy outcomes, menstrual irregularities and early menopause

    by Sevilla-Parra Grecia, Bravo-García Fernanda, Mier y Terán Guevara MariaJose, Montes-Garcia Areli, Schäfer Alejandra, Rodríguez-Ochoa Nínive, Bienvenu Caballero Mercedes, Gonzalez Zenteno Said Gabriel, Peña-Ayala Angélica, Tinajero-Nieto Lizbet, et al.

    Objective: To characterize pregnancy outcomes and menstrual irregularities in Mexican women with systemic lupus erythematosus (SLE) and identify clinical factors associated. Methods: We conducted a cross-sectional study of women with SLE enrolled in the Mexican Lupus Registry (LupusRGMX) between May 2021 and September 2024. Clinical and reproductive data were collected using standardized questionnaires. Menopause was defined as the absence of menstruation for ≥12 consecutive months, and early menopause before age 40. Univariable and multivariable logistic regression analyses were used to identify factors associated with pregnancy complications and early menopause. Results: A total of 210 women were included. Median age was 38 years (IQR 29–46) and median disease duration was 4 years (IQR 1–10). Among women with a history of pregnancy (47%), full-term delivery predominated (61%), while pregnancy loss occurred in 26% and preterm delivery in 13%. Pregnancy complications were reported in 9.6%, most commonly preeclampsia (6.7%). Younger maternal age was independently associated with pregnancy complications (OR 0.89, 95% CI 0.83–0.95) and adverse outcomes (OR 0.95, 95% CI 0.92–0.98). Higher disease activity was associated with complications in univariable analysis. Most pregnancies (68.3%) occurred before diagnosis. Early menopause was observed in 6.2% and was independently associated with longer disease duration. Conclusion: Younger maternal age was independently associated with adverse pregnancy outcomes in women enrolled in the LupusRGMX. Most pregnancies occurred prior to SLE diagnosis. Early menopause was associated with longer disease duration, suggesting the impact of cumulative disease burden on ovarian function.

  • Open Access

    Gene expression profiling of dendritic cell tolerance dysfunction in women with Systemic lupus erythematosus

    by Ana Laura Hernández-Ledesma, Evelia Lorena Coss-Navarrete, Sofia Salazar-Magaña, Diego Ramírez-Espinosa, Lizbet Tinajero-Nieto, Estefania Torres-Valdez, Angélica Peña-Ayala, Guillermo Félix-Rodríguez, Gabriel Frontana-Vázquez, Jair Santiago García-Sotelo, et al.

    Dendritic cells (DCs) are central regulators of immune tolerance, and disturbances in their phenotype and function contribute to the breakdown of self-tolerance in systemic lupus erythematosus (SLE). Tolerogenic DCs (tolDCs), which suppress autoreactive responses and promote peripheral tolerance, are a promising therapeutic focus in autoimmune diseases. Here, we analyzed the transcriptional profiles of in vitro generated DCs derived from monocytes of individuals with SLE and healthy controls to identify disease-specific disruptions in tolerance associated pathways. Interferon stimulated genes (ISGs) emerged as dominant markers across all cellular contexts, with monocytes exhibiting the most substantial enrichment; key ISGs (IFI27, IFI44L, USP18, IFI6) acted as central hubs in regulatory networks, underscoring their diagnostic and pathogenic significance. In tolDCs from SLE donors, lipid metabolism pathways were selectively altered, suggesting impaired synthesis of pro-resolving lipid mediators. Additionally, diminished IL10RA expression and dysregulated IRF4 activity in SLE moDCs indicated intrinsic defects in IL-10 mediated tolerogenic differentiation. Together, these findings suggest that interferon driven transcriptional rewiring, impaired IL-10 signaling, and aberrant lipid metabolic programming converge to compromise DCs tolerogenic capacity in SLE. This highlights key mechanistic pathways that could be targeted to restore immune tolerance and reduce chronic inflammation.